Sebaceous Adenoma Clinical Presentation

  • Author: Grace F Kao, MD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Jan 12, 2012
 

History

  • Patients with sebaceous adenomas typically experience a gradual onset of small, usually less than 0.5 cm in diameter (2-4 mm), smooth, yellow, sometimes speckled papules with central umbilication on the skin of the face or scalp over a period of several months.
  • Some middle-aged and older individuals may have multiple papules (as described above) or nondescript papules on their faces or other parts of their skin surface.
Next

Physical

  • Sebaceous adenomas range from less than 1 cm (usually 2-4 mm) to greater than 5 cm in maximum dimension.
  • Tumors most frequently appear as a yellow, speckled, smooth-surfaced, circumscribed papule or nodule (see image below).A biopsy-proven sebaceous adenoma on the forehead A biopsy-proven sebaceous adenoma on the forehead of a 64-year-old man. The tumor appeared as a dome-shaped, elevated nodule with a circumscribed margin. It measured 8 mm in diameter, with a smooth, shiny, yellow, and speckled appearance. The tumor had a history of slow growth, and the patient had noticed it for more than a year. Note the pearly appearance and the presence of a few capillaries traversing the tumor surface, a feature closely mimicking the clinical appearance of that of a basal cell carcinoma. The total surgical removal of this tumor was uneventful. The patient has not experienced a recurrence.
  • At times, these tumors have a polypoid appearance or central umbilication.
  • Sebaceous adenomas sometimes present as tan or pink-to-red papules.
  • Tumors are commonly located on the face, the scalp, and the neck.
  • Occasionally, tumors may be seen at other sites, including the trunk and the legs.
  • The clinical impression prior to the time of biopsy is usually that of basal cell carcinoma or a nondescript papule without definitive clinical diagnosis.Multiple sebaceous neoplasms on the skin of the chMultiple sebaceous neoplasms on the skin of the chest and the trunk of a 62-year-old man. The tumors were biopsy-proven sebaceous tumors with varying degrees of sebaceous differentiation. The patient was found to have a well-differentiated adenocarcinoma of the colon by subsequent colonoscopy, CT scan, and MRI examination.
Previous
Next

Causes

Sebaceous adenomas form part of the spectrum of the Muir-Torre syndrome. A genetic predisposition exists in some cases of the Muir-Torre syndrome, and this syndrome has been found in association with the so-called cancer family syndrome.

  • The identification of a truncating germline mutation in the mismatch repair (MMR) gene, hMLH1 or hMSH2, by DNA molecular genetic study in some patients having cystic sebaceous tumors with Muir-Torre syndrome highlights the value of recognizing cutaneous markers of internal malignancy.[9]
  • In 1999, Rütten et al[10] studied 19 patients with Muir-Torre syndrome using DNA molecular genetic analysis and reported that 8 (42%) of these patients presented with a cystic variant of sebaceous tumors (including sebaceous adenomas). They concluded that the cystic sebaceous neoplasm is a marker for the MMR-deficient subtype of Muir-Torre syndrome and is associated with a high risk for developing internal malignancies later in life.
  • The genetic disorder in Muir-Torre syndrome is an autosomal dominant inherited germline mutation in one of the DNA mismatch repair genes, most commonly hMSH2.[11] It is inherited with a high degree of penetrance and variable expression, with a male-to-female ratio of 3:2. Children of an individual with Muir-Torre syndrome, therefore, may have a 50% risk of inheriting the cancer predisposition. In families in which the germline mutation can be identified, those individuals who have inherited the mutation should undergo regular screening examinations, particularly of the gastrointestinal tract, colorectum, genitourinary tract, and female genital tract.
Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

Grace F Kao, MD  Clinical Professor of Dermatopathology, Department of Dermatology, University of Maryland School of Medicine and George Washington University Medical School; Director, Dermatopathology Section, Department of Pathology and Laboratory Medicine, Veterans Affairs Maryland Healthcare System, Baltimore, Maryland

Grace F Kao, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and International Society of Dermatopathology

Disclosure: Nothing to disclose.

Specialty Editor Board

Evan R Farmer, MD  Clinical Professor of Pathology and Dermatology, Department of Pathology, Virginia Commonwealth University School of Medicine

Evan R Farmer, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Medical Association, American Society of Dermatopathology, and International Society of Dermatology

Disclosure: Nothing to disclose.

Richard P Vinson, MD  Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Warren R Heymann, MD  Head, Division of Dermatology, Professor, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

The author wishes to thank G. William Moore, MD, PhD, and Lawrence A. Brown, MD, for assistance in reviewing and editing the manuscript and for technical support.

References

  1. Mehregan AH, Pinkus H. Life history of organoid nevi. Special reference to nevus sebaceus of Jadassohn. Arch Dermatol. Jun 1965;91:574-88. [Medline].

  2. Ito K, Sato S, Nishijima A, Hiraga K, Hidano A. Melanogenic melanocytes in human sebaceous glands. Experientia. Apr 15 1976;32(4):511-2. [Medline].

  3. Ormsby AH, Snow JL, Su WP, Goellner JR. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol. May 1995;32(5 Pt 1):711-6. [Medline].

  4. Swanson PE. Monoclonal antibodies to human milk fat globule proteins. In: Wick MR, Siegal GP, eds. Monoclonal antibodies in diagnostic immunohistochemistry. New York, NY: Marcel Dekker; 1988:227-84.

  5. Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol. Oct 1999;21(5):426-31. [Medline].

  6. Shikata N, Kurokawa I, Andachi H, Tsubura A. Expression of androgen receptors in skin appendage tumors: an immunohistochemical study. J Cutan Pathol. Apr 1995;22(2):149-53. [Medline].

  7. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. Mar 1967;54(3):191-5. [Medline].

  8. Torre D. Multiple sebaceous tumors. Arch Dermatol. Nov 1968;98(5):549-51. [Medline].

  9. Ollila S, Fitzpatrick R, Sarantaus L, et al. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Int J Oncol. Jan 2006;28(1):149-53. [Medline].

  10. Rütten A, Burgdorf W, Hugel H, et al. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol. Oct 1999;21(5):405-13. [Medline].

  11. Suspiro A, Fidalgo P, Cravo M, et al. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol. Sep 1998;93(9):1572-4. [Medline].

  12. Heyl J, Mehregan D. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas. J Cutan Pathol. Jan 2008;35(1):40-5. [Medline].

  13. Smith J, Crowe K, McGaughran J, Robertson T. Sebaceous adenoma arising within an ovarian mature cystic teratoma in Muir-Torre syndrome. Ann Diagn Pathol. Jun 16 2011;[Medline].

  14. Landis MN, Davis CL, Bellus GA, Wolverton SE. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy. J Am Acad Dermatol. Nov 2011;65(5):1054-1058.e1. [Medline].

  15. Misago N, Toda S, Narisawa Y. Two histopathologic patterns of well-differentiated extraocular sebaceous carcinoma. J Cutan Pathol. Oct 2011;38(10):767-74. [Medline].

  16. Troy JL, Ackerman AB. Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol. Feb 1984;6(1):7-13. [Medline].

  17. Sachez Yus E, Requena L, Simon P, del Río E. Sebomatricoma: a unifying term that encompasses all benign neoplasms with sebaceous differentiation. Am J Dermatopathol. Jun 1995;17(3):213-21. [Medline].

  18. Banse-Kupin L, Morales A, Barlow M. Torre's syndrome: report of two cases and review of the literature. J Am Acad Dermatol. May 1984;10(5 Pt 1):803-17. [Medline].

  19. Hashimoto K, Mehregan AH, Kumakiri M. Tumors of Skin Appendages. Boston, Mass: Butterworth-Heinemann; 1987.

  20. Latham JA, Redfern CP, Thody AJ, De Kretser TA. Immunohistochemical markers of human sebaceous gland differentiation. J Histochem Cytochem. May 1989;37(5):729-34. [Medline].

  21. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. Br J Dermatol. Sep 1985;113(3):295-301. [Medline].

  22. Misago N, Narisawa Y. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol. Apr 2000;22(2):155-61. [Medline].

  23. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. Dec 2005;6(12):980-7. [Medline].

  24. Steffen C, Ackerman AB. Neoplasms With Sebaceous Differentiation. Philadelphia, Pa: Lea & Febiger; 1992.

  25. Tsalis K, Blouhos K, Vasiliadis K, Tsachalis T, Angelopoulos S, Betsis D. Sebaceous gland tumors and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature. World J Surg Oncol. 2006;4:8. [Medline].

  26. Wick MR, Swanson PE. Cutaneous Adnexal Tumors: A Guide to Pathologic Diagnosis. Chicago, Ill: ASCP Press; 1991.

  27. Zaim MT. Sebocrine adenoma. An adnexal adenoma with sebaceous and apocrine poroma-like differentiation. Am J Dermatopathol. Aug 1988;10(4):311-8. [Medline].

 
Previous
Next
 
A biopsy-proven sebaceous adenoma on the forehead of a 64-year-old man. The tumor appeared as a dome-shaped, elevated nodule with a circumscribed margin. It measured 8 mm in diameter, with a smooth, shiny, yellow, and speckled appearance. The tumor had a history of slow growth, and the patient had noticed it for more than a year. Note the pearly appearance and the presence of a few capillaries traversing the tumor surface, a feature closely mimicking the clinical appearance of that of a basal cell carcinoma. The total surgical removal of this tumor was uneventful. The patient has not experienced a recurrence.
Low-power view of a photomicrograph of sebaceous adenoma. Note the dome-shaped elevation of the epidermal surface, the sharp circumscription from the adjacent dermal tissue, and the slight central cystic appearance with eosinophilic secretory material. Patients with sebaceous tumors showing more prominent cystic change have been found to have DNA abnormalities that are linked to a higher risk of the development of internal malignancies at a later date.
A medium-power view of the well-differentiated SA on the forehead of a 64-year-old man, showing proliferation of well-differentiated sebaceous lobules with central, larger, mature sebocytes and peripheral, smaller, less-differentiated, basaloid, germinative cells. Note that the sebaceous lobules are connected to the overlying epidermis and are slightly off-center in this field; a collection of eosinophilic, pink-colored, keratinous material is present in a dilated follicular ostium within the tumor (hematoxylin and eosin, original magnification X75). In contrast to a sebaceous hyperplasia, a sebaceous adenoma such as seen in this microscopic field contains sebaceous lobules with a 2-cell type and not a single-cell type of sebocytes as seen in the former. The neoplasm was completely removed, with no known recurrences to date.
Higher-power view of a photomicrograph of a sebaceous adenoma. Note the intermingled 2 cell types, ie, well-differentiated pale-staining sebocytes containing vacuolated (bubbly) cytoplasm and smaller, darkly stained, basaloid, less-differentiated matrix cells. An occasional mitotic figure (arrow) was present. The tumor was completely excised, and no recurrence was noted in this patient after 5 years of follow-up (hematoxylin and eosin, original magnification X200).
A close-up, higher-power view of the same sebaceous adenoma. The cytologic details are evident. Notice the predominant, larger sebocytes (arrow) containing pale-staining, bubbly cytoplasm (intracytoplasmic compartmentalization) and a few smaller, basaloid, germinative cells of pilosebaceous structures. The nuclei are vesicular without overt pleomorphism or mitotic activity (hematoxylin and eosin, original magnification X300).
Multiple sebaceous neoplasms on the skin of the chest and the trunk of a 62-year-old man. The tumors were biopsy-proven sebaceous tumors with varying degrees of sebaceous differentiation. The patient was found to have a well-differentiated adenocarcinoma of the colon by subsequent colonoscopy, CT scan, and MRI examination.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.